TRTC 2019 Consortium – Viewpoint is a sponsor and our CSO gives a presentation
September 19, 2019
Sept 20th, 2019 – Madison, Wisconsin. The 2019 Targeted Radionuclide Therapy Consortium is being held at the University of Wisconsin Madison Friday, Sept 20th-Sunday, Sept 22nd, 2019. Viewpoint Molecular Targeting is a proud Gold Industry Sponsor of the event. This event is a gathering of radiologists, radiation oncologists, medical physicists, and laboratory researchers that look at the future of this emerging technology. Our own Chief Science Officer Michael K. Schultz, PhD. will be speaking on such subject about “203Pb & 212Pb Theranostics for Cancer” at 1:30pm on Saturday in the UW Memorial Union – Great Hall. To find out more about this event click this link TRTC 2019.